NEPAFENAC MARKET

INTRODUCTIONNEPAFENAC MARKET

Nepafenac, sold under the brand name Nevanac among others, is anonsteroidal anti-inflammatory drug(NSAID), usually sold as aprescription eye dropsolution (Nevanac) or solution (Ilevro).

It is used to treat pain and inflammation associated withcataractsurgery. Nepafenac is aprodrugofamfenac, an inhibitor ofCOX  activity.

Nepafenac is indicated for use in the treatment of pain and inflammation following cataract surgery.In the European Union nepafenac is also indicated for the reduction in the risk of postoperativemacular edemaassociated with cataract surgery in people with diabetes.

Nepafenac is an NSAID, thought to be a prodrug of amfenac after conversion by ocular tissue hydrolases after penetration via thecornea. Amfenac, like other NSAIDs, is thought to inhibitcyclooxygenaseaction.

Side effectsinclude headache; runny nose; pain or pressure in the face; nausea; vomiting; and dry, itchy, sticky eyes. Serious side effects include red or bloody eyes; foreign body sensation in the eye; sensitivity to light; decreasedvisual acuity; seeing specks or spots; teary eyes; or eye discharge or crusting.

NEPAFENAC MARKET SIZE AND FORECAST

The Global NEPAFENAC market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

NEPAFENAC MARKETNEW PRODUCT LAUNCH

Ilevro - Thismedicationis used to relieveeye pain, irritation, and redness following cataracteyesurgery.Nepafenacbelongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking certain natural substances (prostaglandins) in your body thatcause painand swelling.

Nepafenac ophthalmic suspension is a solution containing pain-relieving and anti-inflammatory medication Nepafenac for use as eye drops to prevent and treat redness, pain and swelling that occurs after cataract surgery and to reduce the risk of postoperative macular edema (swelling of a layer present at the back of the eye) associated with cataract surgery in diabetic patients.

Thismedicationhas to the operatedeye(s) as directed by the doctor. The instructions for use depend on the strength of theeyedrops prescribed.

usingnepafenac0.1%eyedrops, apply it usually 3 times daily starting 1 day before surgery, and continue use on the day of surgery and for 2 weeks after surgery, or as directed by your doctor.

NEPAFENAC MARKETCOMPANY PROFILE

• Neypac
• Xinep
• Nepacin
• Nepastar
• Nepatop

THISNEPAFENAC MARKETREPORT WILL ANSWER FOLLOWING QUESTIONS

1. How many NEPAFENAC  are manufactured per annum globally? Who are the sub-component suppliers in different regions?
2. Cost breakup of a Global NEPAFENAC  and key vendor selection criteria
3. Where is the NEPAFENAC  manufactured? What is the average margin per unit?
4. Market share of Global NEPAFENAC  market manufacturers and their upcoming products
5. Cost advantage for OEMs who manufacture Global NEPAFENAC  in-house
6. key predictions for next 5 years in Global NEPAFENAC  market
7. Average B-2-B NEPAFENAC  market price in all segments
8. Latest trends in NEPAFENAC  market, by every market segment
9. The market size (both volume and value) of the NEPAFENAC  market in 2024-2030 and every year in between?
10. Production breakup of NEPAFENAC  market, by suppliers and their OEM relationship